Brillantes, Rosalie .

HRN: 29-10-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2026
CEFUROXIME 1.5GM (VIAL)
07/08/2026
07/08/2026
IV
1.5
Q8
UTI
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines